Form CORRESP - Correspondence:
SEC Accession No. 0001628280-20-010552
Filing Date
2020-07-22
Accepted
2020-07-22 17:21:19
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 26777
2 GRAPHIC cumberlandlogo1.jpg GRAPHIC 12332
  Complete submission text file 0001628280-20-010552.txt   39394
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations